The Altered Transcriptome and DNA Methylation Profiles of Docetaxel Resistance in Breast Cancer PDX Models-Reference-Cited by-同舟云学术

The Altered Transcriptome and DNA Methylation Profiles of Docetaxel Resistance in Breast Cancer PDX Models

Published:2019-07-18 Issue:10 Volume:17 Page:2063-2076
ISSN:1541-7786
Container-title:Molecular Cancer Research
language:en
Short-container-title:Mol Cancer Res

Author:

Gómez-Miragaya Jorge^ORCID,Morán Sebastián,Calleja-Cervantes Maria Eréndira^ORCID,Collado-Sole Alejandro,Paré Laia,Gómez Antonio^ORCID,Serra Violeta^ORCID,Dobrolecki Lacey E.,Lewis Michael T.,Diaz-Lagares Angel,Eroles Pilar^ORCID,Prat Aleix,Esteller Manel,González-Suárez Eva

Funder

AEI

Susan Komen Foundation

ERC

Instituto de Salud Carlos

Breast Cancer Research Foundation

NIHNCINCI

BCM

ISCIII

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology,Molecular Biology

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perfluorooctanesulfonic acid (PFOS) induced cancer related DNA methylation alterations in human breast cells: A whole genome methylome study;Science of The Total Environment;2024-11

2. A comprehensive study on epigenetic signatures to monitor disease progression and the response to therapy in breast cancer;Biomedical Analysis;2024-09

3. Epigenetic regulation of DNA repair gene program by Hippo/YAP1-TET1 axis mediates sorafenib resistance in HCC;Cellular and Molecular Life Sciences;2024-07-05

4. Insights into molecular mechanisms of chemotherapy resistance in cancer;Translational Oncology;2024-04

5. Mechanisms of sunitinib resistance in renal cell carcinoma and associated opportunities for therapeutics;British Journal of Pharmacology;2023-10-19